JB Capital LLC Cuts Holdings in CVS Health Co. (NYSE:CVS)

JB Capital LLC reduced its position in shares of CVS Health Co. (NYSE:CVS) by 1.9% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 11,060 shares of the pharmacy operator’s stock after selling 213 shares during the quarter. JB Capital LLC’s holdings in CVS Health were worth $696,000 as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of the business. Livelsberger Financial Advisory purchased a new position in CVS Health in the 3rd quarter valued at $31,000. Reston Wealth Management LLC acquired a new stake in CVS Health in the 3rd quarter valued at about $32,000. First Community Trust NA lifted its stake in CVS Health by 116.2% in the 2nd quarter. First Community Trust NA now owns 562 shares of the pharmacy operator’s stock worth $33,000 after purchasing an additional 302 shares in the last quarter. Kathleen S. Wright Associates Inc. purchased a new stake in shares of CVS Health in the third quarter valued at approximately $33,000. Finally, ORG Partners LLC increased its holdings in shares of CVS Health by 11,840.0% in the second quarter. ORG Partners LLC now owns 597 shares of the pharmacy operator’s stock valued at $35,000 after purchasing an additional 592 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have recently commented on the company. UBS Group lifted their price target on CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday. Barclays decreased their target price on shares of CVS Health from $75.00 to $71.00 and set an “overweight” rating on the stock in a report on Thursday. TD Cowen raised shares of CVS Health from a “hold” rating to a “buy” rating and lifted their price target for the company from $59.00 to $85.00 in a research report on Friday, October 4th. Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 8th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a research report on Wednesday, September 4th. Nine investment analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $73.00.

CVS Health Trading Down 7.3 %

NYSE:CVS opened at $57.11 on Friday. CVS Health Co. has a 12-month low of $52.77 and a 12-month high of $83.25. The firm has a market cap of $71.84 billion, a PE ratio of 14.49, a price-to-earnings-growth ratio of 0.82 and a beta of 0.55. The company has a current ratio of 0.86, a quick ratio of 0.66 and a debt-to-equity ratio of 0.83. The stock has a fifty day moving average price of $59.59 and a 200 day moving average price of $59.23.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion during the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business’s revenue for the quarter was up 6.3% on a year-over-year basis. During the same period in the previous year, the company posted $2.21 earnings per share. Sell-side analysts anticipate that CVS Health Co. will post 6.27 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Stockholders of record on Monday, October 21st were given a dividend of $0.665 per share. The ex-dividend date was Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 4.66%. CVS Health’s dividend payout ratio (DPR) is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.